CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+10.99%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$10.6B
AUM Growth
+$10.6B
(+12%)
Cap. Flow
+$751M
Cap. Flow
% of AUM
7.09%
Top 10 Holdings %
Top 10 Hldgs %
22.38%
Holding
858
New
50
Increased
275
Reduced
339
Closed
45
Top Buys
| 1 |
Amgen
AMGN
|
$99.4M |
| 2 |
Merck
MRK
|
$74.3M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$52.7M |
| 4 |
Thermo Fisher Scientific
TMO
|
$36.6M |
| 5 |
Danaher
DHR
|
$36.3M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$86.9M |
| 2 |
Apple
AAPL
|
$60.7M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$31.9M |
| 4 |
Kimberly-Clark
KMB
|
$28.1M |
| 5 |
Arista Networks
ANET
|
$21.4M |
Sector Composition
| 1 | Healthcare | 35.9% |
| 2 | Technology | 20.42% |
| 3 | Consumer Discretionary | 9.53% |
| 4 | Communication Services | 7.72% |
| 5 | Financials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Exact Sciences
EXAS
$9.33B
| $24.7M | 0.23% |
242,580
+54,652
| +29% | +$5.57M |
|
102
Pinduoduo
PDD
$177B
| $24.6M | 0.23% |
332,400
-124,400
| -27% | -$9.22M |
|
103
Sarepta Therapeutics
SRPT
$1.98B
| $24.6M | 0.23% |
174,829
| – | – |
|
104
Alnylam Pharmaceuticals
ALNY
$58.6B
| $24.4M | 0.23% |
167,600
| – | – |
|
105
PTC
PTC
$25.4B
| $24.4M | 0.23% |
294,912
+14,667
| +5% | +$1.21M |
|
106
Xylem
XYL
$34B
| $24.4M | 0.23% |
289,995
+11,168
| +4% | +$939K |
|
107
Tenable Holdings
TENB
$3.72B
| $24.3M | 0.23% |
642,910
+112,691
| +21% | +$4.25M |
|
108
Coca-Cola
KO
$297B
| $24.2M | 0.23% |
489,492
-73,660
| -13% | -$3.64M |
|
109
Mercado Libre
MELI
$120B
| $24.2M | 0.23% |
22,321
-5,603
| -20% | -$6.06M |
|
110
BioNTech
BNTX
$24.1B
| $24.1M | 0.23% |
347,537
-62,776
| -15% | -$4.35M |
|
111
Varonis Systems
VRNS
$6.21B
| $23.8M | 0.22% |
206,266
-40,733
| -16% | -$4.7M |
|
112
Cadence Design Systems
CDNS
$94.6B
| $23.5M | 0.22% |
220,425
+13,071
| +6% | +$1.39M |
|
113
Ecolab
ECL
$77.5B
| $23.5M | 0.22% |
117,462
+20,328
| +21% | +$4.06M |
|
114
SolarEdge
SEDG
$1.97B
| $23.2M | 0.22% |
97,308
+36,160
| +59% | +$8.62M |
|
|
AMTD
115
DELISTED
TD Ameritrade Holding Corp
AMTD
| $23.1M | 0.22% |
590,377
+165,907
| +39% | +$6.49M |
|
116
TAL Education Group
TAL
$6.34B
| $23.1M | 0.22% |
303,793
+205,610
| +209% | +$15.6M |
|
117
Berkshire Hathaway Class B
BRK.B
$1.08T
| $23.1M | 0.22% |
108,411
-5,160
| -5% | -$1.1M |
|
118
Citigroup
C
$175B
| $22.9M | 0.21% |
530,390
-180,852
| -25% | -$7.8M |
|
119
Caterpillar
CAT
$194B
| $22.6M | 0.21% |
151,688
+95,701
| +171% | +$14.3M |
|
120
Iovance Biotherapeutics
IOVA
$800M
| $22.6M | 0.21% |
685,081
-72,575
| -10% | -$2.39M |
|
|
TIF
121
DELISTED
Tiffany & Co.
TIF
| $22.5M | 0.21% |
194,464
+930
| +0.5% | +$108K |
|
|
GLIBA
122
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $22.5M | 0.21% |
+274,689
| New | +$22.5M |
|
|
MRTX
123
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $22.1M | 0.21% |
133,137
+23,076
| +21% | +$3.83M |
|
|
DRNA
124
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $21.8M | 0.2% |
1,209,206
-134,063
| -10% | -$2.41M |
|
125
Kodiak Sciences
KOD
$453M
| $21.7M | 0.2% |
366,348
-32,159
| -8% | -$1.9M |
|